Lista de obras - Francesco Ceci - Dominio Público Uruguay

(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.

artículo científico publicado en 2016

(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel.

artículo científico publicado en 2015

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

artículo científico publicado en 2012

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

artículo científico publicado en 2015

(68)Ga-PSMA PET/CT in prostate cancer

artículo científico publicado en 2017

(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer.

artículo científico publicado en 2015

11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer

artículo científico publicado en 2016

11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.

artículo científico publicado en 2015

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

artículo científico publicado en 2013

11C-choline PET/CT for restaging of bladder cancer.

artículo científico publicado en 2015

11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.

artículo científico publicado en 2015

11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study

artículo científico publicado en 2013

18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival

artículo científico publicado en 2020

18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

artículo científico publicado en 2019

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

artículo científico publicado en 2017

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

artículo científico publicado en 2017

68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report

artículo científico publicado en 2020

A Rare Case of Epididymal Metastasis After Radical Prostatectomy Detected by 68Ga-PSMA PET/CT

scientific article published on 22 December 2016

A new type of prostate cancer imaging. Will 64CuCl2 PET/CT flourish or vanish?

artículo científico publicado en 2017

Current application and future perspectives of PSMA PET imaging in prostate cancer.

artículo científico publicado en 2018

Detection of Sarcomatoid Lung Metastasis With 68GA-PSMA PET/CT in a Patient With Prostate Cancer.

artículo científico publicado en 2016

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions

artículo científico publicado en 2017

Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.

artículo científico publicado en 2014

Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.

artículo científico publicado en 2013

Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?

artículo científico publicado en 2014

Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.

artículo científico publicado en 2016

First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor

scientific article published in 2023

First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection.

artículo científico publicado en 2014

Future Perspective of the Application of Positron Emission Tomography-Computed Tomography-MR Imaging in Musculoskeletal Disorders

artículo científico publicado en 2018

Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy

scientific article published on 15 June 2018

Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy

article

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence

artículo científico publicado en 2017

How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?

artículo científico publicado en 2019

Imaging of Prostate Cancer Using 11C-Choline PET/Computed Tomography

artículo científico publicado en 2017

Imaging of Prostate Cancer Using C-Choline PET/Computed Tomography

scientific article published on 01 August 2018

Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.

artículo científico publicado en 2014

Incidental Detection of Basaloid Thymic Carcinoma With Ga-PSMA-11 PET/CT in a Patient With Recurrent Prostate Cancer

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis

artículo científico publicado en 2017

Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis

artículo científico publicado en 2018

Molecular Imaging and Precision Medicine in Prostate Cancer.

artículo científico publicado en 2016

New aspects of molecular imaging in prostate cancer.

artículo científico publicado en 2017

Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row

artículo científico publicado en 2018

PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer.

artículo científico publicado en 2016

PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer.

artículo científico

Potential impact of 68Ga-PSMA-11 PET/CT on prostate cancer definitive radiation therapy planning.

artículo científico publicado en 2018

Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer

scientific article published on 06 September 2019

Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database

artículo científico publicado en 2020

Preoperative Staging With C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer

artículo científico publicado en 2018

Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way

artículo científico publicado en 2018

Restaging clear cell renal carcinoma with 18F-FDG PET/CT.

artículo científico publicado en 2014

Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by Ga-PSMA-11 PET/CT

article

State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer

scientific article published on 20 September 2018

The influence of PSA flare in mCRPC patients treated with alpha-emitting radiopharmaceuticals

artículo científico publicado en 2018

The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL.

artículo científico publicado en 2013

The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence

artículo científico publicado en 2017

Therapy assessment in prostate cancer using choline and PSMA PET/CT.

artículo científico publicado en 2017

What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply

artículo científico publicado en 2019

Lista de obras de Francesco Ceci

(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.

(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel.

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

(68)Ga-PSMA PET/CT in prostate cancer

(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer.

11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer

11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

11C-choline PET/CT for restaging of bladder cancer.

11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.

11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study

18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival

18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report

A Rare Case of Epididymal Metastasis After Radical Prostatectomy Detected by 68Ga-PSMA PET/CT

A new type of prostate cancer imaging. Will 64CuCl2 PET/CT flourish or vanish?

Current application and future perspectives of PSMA PET imaging in prostate cancer.

Detection of Sarcomatoid Lung Metastasis With 68GA-PSMA PET/CT in a Patient With Prostate Cancer.

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions

Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.

Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.

Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?

Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.

First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor

First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection.

Future Perspective of the Application of Positron Emission Tomography-Computed Tomography-MR Imaging in Musculoskeletal Disorders

Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy

Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence

How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?

Imaging of Prostate Cancer Using 11C-Choline PET/Computed Tomography

Imaging of Prostate Cancer Using C-Choline PET/Computed Tomography

Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.

Incidental Detection of Basaloid Thymic Carcinoma With Ga-PSMA-11 PET/CT in a Patient With Recurrent Prostate Cancer

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis

Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis

Molecular Imaging and Precision Medicine in Prostate Cancer.

New aspects of molecular imaging in prostate cancer.

Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row

PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer.

PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer.

Potential impact of 68Ga-PSMA-11 PET/CT on prostate cancer definitive radiation therapy planning.

Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer

Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database

Preoperative Staging With C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer

Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way

Restaging clear cell renal carcinoma with 18F-FDG PET/CT.

Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by Ga-PSMA-11 PET/CT

State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer

The influence of PSA flare in mCRPC patients treated with alpha-emitting radiopharmaceuticals

The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL.

The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence

Therapy assessment in prostate cancer using choline and PSMA PET/CT.

What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply